In an effort to shed some light on the impact of COMT Val108/158Met polymorphism on breast cancer risk, two previous meta-analyses[17,18] were conducted almost at the same time to explore the relationship between COMT Val108/158Met polymorphism and breast cancer. The gene discussed is COMT; the disease is breast cancer.